← brief for 2026-10-19 · Slowing decline

Antidiabetic medications in the pipeline.

Paper No results yet Peer reviewed

Key takeaways

This review looks at new diabetes drugs being developed. It explains how these drugs target multiple body systems at once. It discusses how they might help with heart, kidney, and liver problems. There are no new trial results in this piece, just a summary of drugs in the testing phase.

Who did this work

Efstathiadou ZA · Gogakos AI · Divaris E · Kostopoulos G · Makri E

Source

Paper · PubMed, the drug frontier · 2026 Oct 19
https://pubmed.ncbi.nlm.nih.gov/42895615/